Here are relevant reports on : ai-in-market-research
-
Artificial Intelligence (AI) Market by Offering (Infrastructure, Software, Services), Technology (ML, NLP, Generative AI), Business Function (Operations & Supply Chain, Finance & Accounting), Enterprise Application, and End User - Global Forecast to 2032
The market for artificial intelligence is slated to expand from USD 371.71 billion in 2025 to USD 2,407.02 billion by 2032, at a CAGR of 30.6% during the forecast period. The major players in the AI market include Google (US), Microsoft (US), IBM (US), Oracle (US), AWS (US), Intel (US), Salesforce (US), SAP (Germany), AMD (US), Qualcomm (US), Cisco (US), Meta (US), HPE (US), Siemens (Germany), NVIDIA (US), Baidu (China), SAS Institute (US), OpenAI (US), Huawei (China), Alibaba Cloud (China), Centific (US), Fractal Analytics (US), Tiger Analytics (US), Quantiphi (US), Databricks (US), iMerit (US), Telus International (Canada), Innodata (US), Sama (US), C3 AI (US), HQE Systems (US), Appier (Taiwan), Adept (US), H20.AI (US), Spot AI (US), Anthropic (US), Cohere (Canada), Inbenta (US), Character.ai (US), DeepL (Germany), Inflection AI (US), Arrow AI (US), Observe.ai (US), Anyscale (US), AI21 Labs (Israel), Persado (US), Dialpad (US), Graphcore (UK), Shield AI (US), Gamaya (Switzerland), Arthur AI (US), ADA (Canada), Mostly AI (Austria), Metropolis Technologies (US), Cerebras (US), Jasper (US), Soundful (US), Writesonic (US), One AI (Israel), Synthesia (UK), Snorkel (US), Labelbox (US), Appen (US), and Cogito Tech (US).
- Published: April 2025
- Price: $ 4950
- TOC Available:
-
Asia Pacific Biomarkers Market by Offering (Consumables, Software, Services), Type (Safety, Efficacy), Research Area (Genomics, Proteomics), Technology (PCR, MS), Disease (Cancer, Infectious), Application (Diagnostic, Research)- Forecast to 2030
The Asia Pacific biomarkers Market, valued at US$13.51 billion in 2024, stood at US$14.73 billion in 2025 and is projected to advance at a resilient CAGR of 12.4% from 2025 to 2030, culminating in a forecasted valuation of US$26.40 billion by the end of the period. A biomarker (short for biological marker) is a measurable indicator of a biological condition or process, often used to diagnose diseases, predict disease progression, and evaluate treatment response; this market includes consumables, services, and software used for biomarker-related research.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Europe Biomarkers Market by Offering (Consumables, Software, Services), Type (Safety, Efficacy), Research Area (Genomics, Proteomics), Technology (PCR, MS), Disease (Cancer, Infectious), Application (Diagnostic, Research)- Forecast to 2030
The Europe biomarkers Market, valued at US$16.40 billion in 2024, stood at US$17.46 billion in 2025 and is projected to advance at a resilient CAGR of 10.0% from 2025 to 2030, culminating in a forecasted valuation of US$28.11 billion by the end of the period. A biomarker (short for biological marker) is a measurable indicator of a biological condition or process, often used to diagnose diseases, predict disease progression, and evaluate treatment response; this market includes consumables, services, and software used for biomarker-related research.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Cell Sorting Market by Technology (FACS-based Droplet Sorting, MACS, Microfluidics), Product (Cell Sorters, Reagents, Consumables), Application (Research, Clinical), End User (Research Institutes, Biopharma Companies, Medical Schools) - Forecasts to 2021
The global cell sorting market is projected to grow at a CAGR of 7.0%. Factors such as technological advancements in cell sorters, rising funding and investments for development of technologically advanced cell sorters, and growing adoption of cell sorting techniques in research activities are driving the growth of this market. The market is further driven by factors such as the growing prevalence of HIV/AIDS and cancer, expanding pharmaceutical and biotechnology industries, and launch of specific reagents for specific applications. However, factors such as the high cost of instruments and lack of awareness & technical knowledge regarding the use of cell sorters are hampering the growth of this market.
- Published: January 2017
- Price: $ 4950
- TOC Available:
-
Emotion AI Market by Solutions (Emotion Recognition, Emotion AI SDKs and APIs, Emotion Analytics), Type (Text-Focused, Voice-Focused, Video & Multimodal), Technology (Machine Learning, NLP, Computer Vision) - Global Forecast to 2030
The Emotion AI market is projected to reach USD 9.01 billion by 2030, at a CAGR of 21.9% during the forecast period. The report profiles key players such as IBM (US), Microsoft (US), Google (US), Amazon (US), Smart Eye (Sweden), Entropik Tech (India), Uniphore (US), Audeering GmbH (Germany), VIER GmbH (Germany), Cognitec (Germany), Symanto (Germany), Realeyes (UK), CIPIA Vision (Israel), Noldus (Netherlands), Cogito (US), Morphcast (US), Voicesense (Israel), Superceed (Malaysia), Siena AI (US), Opsis (Singapore), Behavioral Signals (US), Hume (US), Kairos (US), Beemotion.AI (Australia), Intelligent Voice (UK), Davi (France), Utrigg (Ukraine), AttentionKart (India) and VERN AI (US).
- Published: December 2024
- Price: $ 4950
- TOC Available:
-
Research Antibodies & Reagents Market by Product (Antibodies (Type, Form, Source, Research Area), Reagents), Technology (Western blot, Flow Cytometry, ELISA), Application (Proteomics, Genomics), End User (Pharma, Biotech, CROs) & Region - Global forecast to 2028
The global research antibodies & reagents market, valued at US$1.3 billion in 2022, stood at US$1.8 billion in 2023 and is projected to advance at a resilient CAGR of 45.6% from 2023 to 2028, culminating in a forecasted valuation of US$12.1 billion by the end of the period. The growth of this market is largely driven by an increase in research activity—especially in the life sciences industry—along with growing industry-academia collaborations are a primary growth driver for this market.
- Published: October 2023
- Price: $ 4950
- TOC Available:
-
qPCR Reagents Market by Detection (Dye-based, Probe-based), Packaging (qPCR Core Kits, Master Mixes), End User (Hospitals, Diagnostic Centers, Academia, Research Labs, CRO), Application (Diagnostic, Research, Forensic) - Global Forecast to 2020
The global qPCR reagents market size is projected to grow at a CAGR of 7.7%. Market growth can be attributed to factors such as rising patient population base for infectious diseases & genetic disorders, coupled with growing geriatric population, technological advancements in the life sciences sector, increasing public-private investments, funds, and grants for PCR-based research, and the successful completion of the human genome project. However, technical limitations associated with qPCR are restraining the growth of this market.
- Published: January 2016
- Price: $ 4950
- TOC Available:
-
AI in Mining Market by Offering (Software, Services), Mining Type (Surface, Underground), Deployment Mode (On-Premises, Cloud, Hybrid), Technology (Generative AI, Machine Learning, NLP), Application, Vertical, and Region - Global Forecast to 2032
The AI in mining market is expected to grow from USD 2.60 billion in 2025 to USD 9.93 billion by 2032, at a compound annual growth rate (CAGR) of 21.1%during the forecast period. The Key Players Caterpillar (US), Komatsu Ltd. (Japan), Sandvik AB (Sweden), Epiroc AB (Sweden), Hitachi Construction Machinery Co., Ltd. (Japan), Hexagon AB (Sweden), Rockwell Automation (US), Siemens (Germany), Trimble Inc. (US), and ABB (Switzerland).
- Published: December 2025
- Price: $ 4950
- TOC Available:
-
Expression Vectors Market by Host Type (Bacterial/E.Coli, Mammalian/CHO, Insect/Baculovirus, and Yeast), Application (Therapeutic, Research, and Industrial), End User (Pharmaceutical, Biotechnology, CROs & CMOs, and Academic Research) - Forecast to 2020
The expression vectors market is expected to reach $317.1 Million by 2020 from $242.7 Million in 2015, growing at a CAGR of 5.5% from 2015 to 2020. Major factors driving the growth of this market include the increasing demand of protein-based drugs (biologics); high prevalence of lifestyle diseases, infectious diseases, and genetic disorders; and increasing funding for protein research. On the other hand, high market consolidation, which increases entry barriers, and high cost of protein therapy are the major factors restraining the growth of this market.
- Published: June 2015
- Price: $ 4950
- TOC Available:
-
AI Vision Market by Vision Software (API, SDK), Vision Platform, Behavioral Analysis, Optical Character Recognition, Spatial Analysis, Image Recognition, Heatmap Analysis, Machine Learning, Deep Learning, CNN, Generative AI – Global Forecast to 2029
The global AI vision market is expected to grow from USD 14.85 billion in 2024 to USD 43.02 billion in 2029, at a compound annual growth rate (CAGR) of 23.7% during the forecast period.The key players NVIDIA Corporation (US), Microsoft Corporation (US), Intel Corporation (US), Alphabet Inc. (US), Amazon.com, Inc. (US), IBM (US), Oracle (US), Cognex Corporation (US), Qualcomm Technologies, Inc. (US), STMicroelectronics (Switzerland).
- Published: January 2025
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
